pillbase.ru

Cyramza

Active substance: ramucirumab

ramucirumab

Centralised EU authorisationActive

Marketing holder: Eli Lilly Nederland B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • CYRAMZA
    SOLUTION · RAMUCIRUMAB 10 mg/mL
    0002-7678
    Eli Lilly and Company
  • CYRAMZA
    SOLUTION · RAMUCIRUMAB 10 mg/mL
    0002-7669
    Eli Lilly and Company
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-dde2-70ec-8554-fc7a71a01476,01a1208d-d0b7-7133-b918-66a34488e63c;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/002829
Registration status
Active
ATC code
L01FX06
Sources
  • product · EMA · EMEA/H/C/002829 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/002829 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/002829 · Verified 2026-10-09